Journal of Molecular Medicine

, Volume 86, Issue 1, pp 99–103 | Cite as

Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction

  • Massimo Mangino
  • Peter Braund
  • Ravi Singh
  • Richard Steeds
  • Suzanne Stevens
  • Kevin S Channer
  • Nilesh J Samani
Rapid Communication

Abstract

The notion that coronary atherosclerosis and its most severe phenotype, myocardial infarction (MI), are chronic inflammatory diseases is supported by several lines of evidence. Interleukins (ILs) are important mediators and modulators of inflammation. Specific polymorphisms in the genes encoding subunits of IL-23 (IL-12B) and its receptor (IL-23R) have recently been consistently found to be associated with chronic immune-mediated diseases. In this study, we explored the hypothesis that these variants also affect the risk of MI. We conducted a case–control association study on a cohort of 738 British Caucasian MI patients and 716 population controls. We tested four variants (rs11209026, rs7517847, rs1343151, rs10889677) of IL-23R and the A1188C polymorphism (rs3212227) of IL-12B. There was no association of any IL-23R (rs11209026, p = 0.82; rs7517847, p = 0.87; rs1343151, p = 0.85; rs10889677, p = 0.48) or IL-12B (rs3212227, p = 0.32) polymorphisms with MI. Stratification for age, gender and other cardiovascular risk factors did not affect the findings. These results indicate that unlike other chronic inflammatory diseases, the examined variants are unlikely to be major contributors to the pathogenesis of MI.

Keywords

Myocardial infarction IL-23 IL-23R Inflammation 

Notes

Acknowledgements

NJS holds a British Heart Foundation Chair of Cardiology.

References

  1. 1.
    Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C (2002) World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106:1602–1605PubMedCrossRefGoogle Scholar
  2. 2.
    Topol EJ, Smith J, Plow EF, Wang QK (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15:R117–R123PubMedCrossRefGoogle Scholar
  3. 3.
    Lusis AJ (2000) Atherosclerosis. Nature 407:233–241PubMedCrossRefGoogle Scholar
  4. 4.
    Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874PubMedCrossRefGoogle Scholar
  5. 5.
    Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126PubMedCrossRefGoogle Scholar
  6. 6.
    Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK (1999) Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145:33–43PubMedCrossRefGoogle Scholar
  7. 7.
    Lankford CS, Frucht DM (2003) A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 73:49–56PubMedCrossRefGoogle Scholar
  8. 8.
    Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725PubMedCrossRefGoogle Scholar
  9. 9.
    Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273–290PubMedCrossRefGoogle Scholar
  10. 10.
    Morahan G, Huang D, Ymer SI, Cancilla MR, Stephen K, Dabadghao P, Werther G, Tait BD, Harrison LC, Colman PG (2001) Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 27:218–221PubMedCrossRefGoogle Scholar
  11. 11.
    Windsor L, Morahan G, Huang D, McCann V, Jones T, James I, Christiansen FT, Price P (2004) Alleles of the IL12B . 3¢UTR. associate with late onset of type 1 diabetes. Hum Immunol 65:1432–1436PubMedCrossRefGoogle Scholar
  12. 12.
    van Veen T, Crusius JB, Schrijver HM, Bouma G, Killestein J, van Winsen L, Salvador Pena A, Polman CH, Uitdehaag BM (2001) Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 50:275PubMedCrossRefGoogle Scholar
  13. 13.
    Momiyama Y, Ohmori R, Nagano M, Kato R, Taniguchi H, Egashira T, Nakamura H, Ohsuzu F (2005) Polymorphism of the 3' -untranslated region of interleukin-12 p40 gene is not associated with the presence or severity of coronary artery disease. Circ J 69:793–797PubMedCrossRefGoogle Scholar
  14. 14.
    Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, To W, Wagner J, O’Farrell AM, McClanahan T, Zurawski S, Hannum C, Gorman D, Rennick DM, Kastelein RA, de Waal Malefyt R, Moore KW (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168:5699–5708PubMedGoogle Scholar
  15. 15.
    Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463PubMedCrossRefGoogle Scholar
  16. 16.
    The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678CrossRefGoogle Scholar
  17. 17.
    Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39:596–604PubMedCrossRefGoogle Scholar
  18. 18.
    Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abkevic V, Burden AD, Lanchbury J, Barker JN, Trembath RC, Nestle FO (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201–206PubMedCrossRefGoogle Scholar
  19. 19.
    Steeds R, Adams M, Smith P, Channer K, Samani NJ (1998) Distribution of tissue plasminogen activator insertion/deletion polymorphism in myocardial infarction and control subjects. Thromb Haemost 79:980–984PubMedGoogle Scholar
  20. 20.
    Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ (2003) White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 23:842–846PubMedCrossRefGoogle Scholar
  21. 21.
    Mangino M, Braund P, Singh R, Steeds R, Thompson JR, Channer K, Samani NJ (2007) LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis (in press), DOI  10.1016/j.atherosclerosis.2006.10.004
  22. 22.
    WHO (1979) Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 59:607–609Google Scholar
  23. 23.
    Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5. ¢. nuclease assay. Genet Anal 14:143–149PubMedGoogle Scholar
  24. 24.
    Gauderman WJ (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21:35–50PubMedCrossRefGoogle Scholar
  25. 25.
    Petersen S, Peto V, Scarbough P, Rayner M (2005) Coronary heart disease statistics. British Heart Foundation, LondonGoogle Scholar
  26. 26.
    Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRefGoogle Scholar
  27. 27.
    WHO (2003) The International HapMap Project. Nature 426:789–796CrossRefGoogle Scholar
  28. 28.
    McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488–1491PubMedCrossRefGoogle Scholar
  29. 29.
    Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357:443–453PubMedCrossRefGoogle Scholar
  30. 30.
    Van Limbergen JE, Russell RK, Nimmo ER, Drummond HE, Smith L, Anderson NH, Davies G, Gillett PM, McGrogan P, Hassan K, Weaver LT, Bisset MW, Mahdi G, Wilson DC, Satsangi J (2007) IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 56:1173–1174PubMedCrossRefGoogle Scholar
  31. 31.
    Tremelling M, Cummings F, Fisher SA, Mansfield J, Gwilliam R, Keniry A, Nimmo ER, Drummond H, Onnie CM, Prescott NJ, Sanderson J, Bredin F, Berzuini C, Forbes A, Lewis CM, Cardon L, Deloukas P, Jewell D, Mathew CG, Parkes M, Satsangi J (2007) IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132:1657–1664PubMedCrossRefGoogle Scholar
  32. 32.
    Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ (2004) Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case–control study. Eur Heart J 25:459–467PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Massimo Mangino
    • 1
  • Peter Braund
    • 1
  • Ravi Singh
    • 1
  • Richard Steeds
    • 2
  • Suzanne Stevens
    • 1
  • Kevin S Channer
    • 2
  • Nilesh J Samani
    • 1
  1. 1.Department of Cardiovascular Sciences, Clinical Sciences Wing, Glenfield HospitalUniversity of LeicesterLeicesterUK
  2. 2.Department of CardiologyRoyal Hallamshire HospitalSheffieldUK

Personalised recommendations